References
- O'Connor R, Schwartz JB. (1985). Spheronization. II: Drug release from drug–diluents mixtures. Drug Dev Ind Pharm, 11:1837–57.
- Basit AW, Newton JM, Lacey LF. (1999). Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose. Pharm Dev Technol, 4:499–505.
- Okada T, Nakahara H, Isaka H. (1987). Adsorption of drugs and microcrystalline cellulose suspended in aqueous solutions. Chem Pharm Bull, 35:761–8.
- Trivedi NR, Rajan MG, Johnson JR, Shukla AJ. (2007). Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process. Crit Rev Ther Drug Carrier Syst, 24:1–40.
- Dukic-Ott A, Thommes M, Remon JP, Kleinebudde P, Vervaet C. (2009). Production of pellets via extrusion–spheronisation without the incorporation of microcrystalline cellulose: A critical review. Eur J Pharm Biopharm, 71:38–46.
- Liew CV, Gu L, Soh JLP, Heng PWS. (2005). Functionality of cross-linked polyvinylpyrrolidone as a spheronizing aid: A promising alternative to microcrystalline cellulose. Pharm Res, 22:1387–98.
- Bühler V. (2008). Kollidon. 9th revised. BASF, 13:178–9.
- Gestis Datenbank. (2007). Stoffdatenbank der Deutschen Gesetzlichen Unfall-versicherung.
- Sigma-Aldrich. (2006). Safety data sheet.
- NRF, ABDA. (2006). Govi Verlag, Eschborn.
- Thommes M, Kleinebudde P. (2006). Use of carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronization. Part II. Eur J Pharm Biopharm, 63:68–75.
- Pharm Eur 6th Edition. (6.2). (2008). Govi-Verlag, D 65728 Eschborn.
- USP 31—NF26. (2008). The United States Pharmacopoeia, the national formulary, Rockville: United States Pharmacopeial Convention Inc.
- Kleinebudde P. (1997). Pharmaceutical pellets by extrusion/spheronization, Habilitation, Kiel.